ASK ABOUT OUR PRICE MATCH POLICY
QUESTION? CONTACT US
26,000+ 5-STAR RATINGS ON SHOPPER APPROVED
Colorectal cancer is the second leading cause of cancerrelated deaths in the United States for both women and men.
This disease surpasses both breast and prostate cancer in mortality, second only to lung cancer in the number of cancer deaths. Despite the fact that it is highly preventable, it was estimated that 148,610 new cases of colorectal cancer would be diagnosed and 49,960 people would die from the disease in 2008.
According to the American Cancer Society Cancer Facts and Figures 2008, “this decrease reflects declining incidence rates and improvements in early detection.”
Quidel’s CLIA-waived QuickVue iFOB test is an easy to perform diagnostic tool used to detect the presence of blood in stool specimens. Blood in the stool is an indication of a number of gastrointestinal disorders, including colorectal cancer.
Simply add six (6) drops of the buffered specimen solution into the cassette sample well and read the results in 5 to 10 minutes. The QuickVue iFOB test requires only one specimen, and because it is specific to human hemoglobin, patients are not required to adhere to strict dietary or medication restrictions. The result is a more patient friendly test that is easier to complete. Additionally, immunochemical FOB tests are more analytically sensitive than traditional Guaiac based methods. The QuickVue iFOB test has the potential to increase patient compliance and offers superior analytical performance (as compared to Guaiac tests) to positively impact both patient care and satisfaction.
|California Prop 65||
⚠️ WARNING: This product can expose you to chemicals including arsenic, which is known to the State of California to cause cancer. For more information, visit Proposition 65